(Q45594132)

English

Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients

scientific article published in October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

based on heuristic

inferred from title

Epstein–Barr virus

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Daorong Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Charlotte Tammik

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Jie-Zhi Zou

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Ingemar Ernberg

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Olle Ringden

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Victor Levitsky

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

publication date

1 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Clinical Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

518-524

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

EBV persistence in memory B cells in vivo.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

Serial detection of Epstein-Barr virus DNA in sera and peripheral blood leukocyte samples of pediatric renal allograft recipients with persistent mononucleosis-like symptoms defines patients at risk to develop post-transplant lymphoproliferative dis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

Lymphoproliferative disorders involving Epstein-Barr virus after hemopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

Epstein-Barr virus and post-transplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

Post-transplant lymphoproliferative disorder: a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

Infection of primary human monocytes by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00198.X

21 January 2018

Identifiers

10.1111/J.1399-0012.2004.00198.X

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45594132&oldid=2077426382"